Charles Schwab

Charles Schwab Portfolio holdings

AUM $626B
1-Year Est. Return 22.01%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Quarter Est. Return
1 Year Est. Return
+22.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$578B
AUM Growth
+$44.7B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,634
New
Increased
Reduced
Closed

Top Buys

1 +$5.15B
2 +$1.3B
3 +$831M
4
MSFT icon
Microsoft
MSFT
+$801M
5
NVDA icon
NVIDIA
NVDA
+$726M

Sector Composition

1 Technology 24.59%
2 Financials 11.81%
3 Healthcare 9.33%
4 Consumer Discretionary 9.25%
5 Industrials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBIO icon
3426
Generation Bio
GBIO
$38.5M
$75.8K ﹤0.01%
23,686
-11,958
ACRV icon
3427
Acrivon Therapeutics
ACRV
$64.2M
$75.7K ﹤0.01%
63,636
-47,684
LPTH icon
3428
Lightpath Technologies
LPTH
$357M
$74.5K ﹤0.01%
24,173
GNLX icon
3429
Genelux
GNLX
$227M
$71.8K ﹤0.01%
25,000
IDN icon
3430
Intellicheck
IDN
$88.6M
$69.9K ﹤0.01%
12,962
VXRT
3431
DELISTED
Vaxart
VXRT
$69.5K ﹤0.01%
153,847
+300
AGEN
3432
Agenus
AGEN
$146M
$68.8K ﹤0.01%
15,061
-48,624
GOCO icon
3433
GoHealth
GOCO
$55M
$66.9K ﹤0.01%
12,060
-3,311
INFU icon
3434
InfuSystem Holdings
INFU
$212M
$66.5K ﹤0.01%
10,655
-46,723
ATOS icon
3435
Atossa Therapeutics
ATOS
$107M
$66.4K ﹤0.01%
80,000
-342,582
SBC
3436
SBC Medical Group
SBC
$352M
$66.2K ﹤0.01%
+14,267
PRLD icon
3437
Prelude Therapeutics
PRLD
$78.1M
$65.4K ﹤0.01%
80,845
-33,205
RNXT icon
3438
RenovoRx
RNXT
$37.7M
$65K ﹤0.01%
49,232
LCTX icon
3439
Lineage Cell Therapeutics
LCTX
$417M
$62K ﹤0.01%
68,275
-434,918
ONDS icon
3440
Ondas Holdings
ONDS
$2.07B
$61.4K ﹤0.01%
32,000
NNBR icon
3441
NN Inc
NNBR
$79.3M
$59.6K ﹤0.01%
28,401
-108,301
VGAS icon
3442
Verde Clean Fuels
VGAS
$70.8M
$58.9K ﹤0.01%
+17,113
COYA icon
3443
Coya Therapeutics
COYA
$122M
$57.5K ﹤0.01%
10,000
FLL icon
3444
Full House Resorts
FLL
$95M
$55.8K ﹤0.01%
15,255
-80,111
ALXO icon
3445
ALX Oncology
ALXO
$69.9M
$55.4K ﹤0.01%
133,433
-77,618
ATLN
3446
Atlantic International
ATLN
$143M
$54.2K ﹤0.01%
+26,705
TWNP
3447
Twin Hospitality Group
TWNP
$192M
$53.2K ﹤0.01%
11,772
MCHX icon
3448
Marchex
MCHX
$72.4M
$52.5K ﹤0.01%
24,313
AMPY icon
3449
Amplify Energy
AMPY
$233M
$52.4K ﹤0.01%
16,376
-96,966
DHX icon
3450
DHI Group
DHX
$83.1M
$52.3K ﹤0.01%
17,605